Impact of the use of oral antiviral agents on the risk of hospitalization in community COVID-19 patients.
Terry Cheuk Fung YipGrace Chung Yan LuiMandy Sze Man LaiVincent Wai Sun WongYee Kit TseBosco Hon Ming MaElsie HuiMaria Kw LeungHenry Lik Yuen ChanDavid Shu Cheong HuiGrace Lai-Hung WongPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Use of nirmatrelvir/ritonavir but not molnupiravir was associated with a reduced risk of hospitalization in real-world non-hospitalized COVID-19 patients.